NewAmsterdam Pharma Co N.V.
NAMSCIK 0001936258 · Every Form 4 filed by insiders at this issuer.
Filings
12
Latest Mar 28, 2024
Unique insiders
10
Showing
12 of 12
Page 1
Top insiders
Most active reporters at NewAmsterdam Pharma Co N.V.
| Name | Roles | Filings |
|---|---|---|
| Kastelein Johannes Jacob Pieter | OfficerDirector | 2 |
| LANGE LOUIS G | Director | 2 |
| Davidson Michael H. | OfficerDirector | 1 |
| Kling Douglas F | Officer | 1 |
| Kooij Louise Frederika | Officer | 1 |
| Lewis William | Director | 1 |
| Smither John W | Director | 1 |
| Somaiya Mayur Ian | Officer | 1 |
| Topper James N | Director | 1 |
| van der Kamp Hilde Johanna | Director | 1 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 28, 2024 | Topper James N Director | P | 8,429 | $21.50 | $181,224 | |
| Mar 27, 2024 | Kastelein Johannes Jacob Pieter Chief Scientific Officer · Director | S | 190,476 | $21.50 | $4,095,234 | |
| Feb 21, 2024 | LANGE LOUIS G Director | P | 5,000 | $19.00 | $95,000 | |
| Jan 8, 2024 | Lewis William Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Somaiya Mayur Ian Chief Financial Officer | Holdings only | — | — | — | |
| Jan 3, 2024 | Smither John W Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Davidson Michael H. Chief Executive Officer · Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Kastelein Johannes Jacob Pieter Chief Scientific Officer · Director | Holdings only | — | — | — | |
| Jan 3, 2024 | LANGE LOUIS G Director | Holdings only | — | — | — | |
| Jan 3, 2024 | van der Kamp Hilde Johanna Director | Holdings only | — | — | — | |
| Jan 3, 2024 | Kling Douglas F Chief Operating Officer | Holdings only | — | — | — | |
| Jan 3, 2024 | Kooij Louise Frederika Chief Accounting Officer | Holdings only | — | — | — |
Showing 1–12 of 12
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.